← Every applicant
Boehringer Ingelheim FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| JASCAYDNew drugDec 19, 2025TABLET, ORAL |
| JASCAYDNew drugOct 7, 2025TABLET, ORAL |
| HERNEXEOSNew drugAug 8, 2025TABLET, ORAL |
| PRADAXANew drugJun 21, 2021PELLETS, ORAL |